Monopar Therapeutics Inc (MNPR)
0.768
+0.01
(+1.39%)
USD |
NASDAQ |
May 07, 16:00
0.768
0.00 (0.00%)
After-Hours: 20:00
Monopar Therapeutics EPS Diluted (Quarterly): -0.12 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.12 |
September 30, 2023 | -0.14 |
June 30, 2023 | -0.16 |
March 31, 2023 | -0.19 |
December 31, 2022 | -0.23 |
September 30, 2022 | -0.19 |
June 30, 2022 | -0.22 |
March 31, 2022 | -0.19 |
December 31, 2021 | -0.21 |
September 30, 2021 | -0.20 |
June 30, 2021 | -0.17 |
March 31, 2021 | -0.16 |
December 31, 2020 | -0.19 |
September 30, 2020 | -0.15 |
Date | Value |
---|---|
June 30, 2020 | -0.14 |
March 31, 2020 | -0.10 |
December 31, 2019 | -0.114 |
September 30, 2019 | -0.0706 |
June 30, 2019 | -0.0869 |
March 31, 2019 | -0.1321 |
December 31, 2018 | -0.0854 |
September 30, 2018 | -0.0614 |
June 30, 2018 | -0.0713 |
March 31, 2018 | -0.0841 |
December 31, 2017 | -0.0685 |
September 30, 2017 | -1.428 |
June 30, 2017 | -0.0568 |
March 31, 2017 | -0.0358 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.23
Minimum
Dec 2022
-0.0706
Maximum
Sep 2019
-0.1596
Average
-0.16
Median
Mar 2021
EPS Diluted (Quarterly) Benchmarks
Motus GI Holdings Inc | -1.813 |
SeaStar Medical Holding Corp | -0.2074 |
Perspective Therapeutics Inc | -0.09 |
Electromed Inc | 0.19 |
Xtant Medical Holdings Inc | -0.03 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -1.814M |
Total Expenses (Quarterly) | 1.912M |
Enterprise Value | 5.956M |
Earnings Yield | -79.43% |